Publications

  1. Shanafelt TD, Raymond M, Horn L, Moynihan T, Collichio F, Chew H, Kosty MP, Satele D, Sloan J, Gradishar WJ. Oncology Fellows' Career Plans, Expectations, and Well-Being: Do Fellows Know What They Are Getting Into? J Clin Oncol. 2014 Jul 21.
    View PubMed
  2. Ojha J, Secreto C, Rabe K, da Silva JA, Tschumper R, Van Dyke D, Slager S, Fonseca R, Shanafelt T, Kay N, Braggio E. Monoclonal B-cell lymphocytosis is characterized by mutations in CLL putative driver genes and clonal heterogeneity clonal competition many years prior to disease progression. Leukemia. 2014 Jul 18.
    View PubMed
  3. Pflug N, Bahlo J, Shanafelt TD, Eichhorst BF, Bergmann MA, Elter T, Bauer K, Malchau G, Rabe KG, Stilgenbauer S, Dohner H, Jager U, Eckart MJ, Hopfinger G, Busch R, Fink AM, Wendtner CM, Fischer K, Kay NE, Hallek M. Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia. Blood. 2014 Jul 3; 124(1):49-62. Epub 2014 May 05.
    View PubMed
  4. Call TG, Norman AD, Hanson CA, Achenbach SJ, Kay NE, Zent CS, Ding W, Cerhan JR, Rabe KG, Vachon CM, Hallberg EJ, Shanafelt TD, Slager SL. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines. Cancer. 2014 Jul 1; 120(13):2000-5. Epub 2014 Apr 07.
    View PubMed
  5. Shanafelt TD, Raymond M, Kosty M, Satele D, Horn L, Pippen J, Chu Q, Chew H, Clark WB, Hanley AE, Sloan J, Gradishar WJ. Satisfaction with work-life balance and the career and retirement plans of US oncologists. J Clin Oncol. 2014 Apr 10; 32(11):1127-35. Epub 2014 Mar 10.
    View PubMed
  6. West CP, Dyrbye LN, Rabatin JT, Call TG, Davidson JH, Multari A, Romanski SA, Hellyer JM, Sloan JA, Shanafelt TD. Intervention to promote physician well-being, job satisfaction, and professionalism: a randomized clinical trial. JAMA Intern Med. 2014 Apr; 174(4):527-33.
    View PubMed
  7. Bulian P, Shanafelt TD, Fegan C, Zucchetto A, Cro L, Nuckel H, Baldini L, Kurtova AV, Ferrajoli A, Burger JA, Gaidano G, Del Poeta G, Pepper C, Rossi D, Gattei V. CD49d is the strongest flow cytometry-based predictor of overall survival in chronic lymphocytic leukemia. J Clin Oncol. 2014 Mar 20; 32(9):897-904. Epub 2014 Feb 10.
    View PubMed
  8. Parikh SA, Kay NE, Shanafelt TD. How we treat Richter syndrome. Blood. 2014 Mar 13; 123(11):1647-57. Epub 2014 Jan 13.
    View PubMed
  9. Shanafelt TD, Gradishar WJ, Kosty M, Satele D, Chew H, Horn L, Clark B, Hanley AE, Chu Q, Pippen J, Sloan J, Raymond M. Burnout and career satisfaction among US oncologists. J Clin Oncol. 2014 Mar 1; 32(7):678-86. Epub 2014 Jan 27.
    View PubMed
  10. Dyrbye LN, West CP, Satele D, Boone S, Tan L, Sloan J, Shanafelt TD. Burnout among U.S. medical students, residents, and early career physicians relative to the general U.S. population. Acad Med. 2014 Mar; 89(3):443-51.
    View PubMed
  11. Roberts DL, Shanafelt TD, Dyrbye LN, West CP. A national comparison of burnout and work-life balance among internal medicine hospitalists and outpatient general internists. J Hosp Med. 2014 Mar; 9(3):176-81. Epub 2014 Jan 16.
    View PubMed
  12. Brewer JD, Habermann TM, Shanafelt TD. Lymphoma-associated skin cancer: incidence, natural history, and clinical management. Int J Dermatol. 2014 Mar; 53(3):267-74. Epub 2013 Dec 10.
    View PubMed
  13. Ratterman M, Kruczek K, Sulo S, Shanafelt TD, Kay NE, Nabhan C. Extramedullary chronic lymphocytic leukemia: systematic analysis of cases reported between 1975 and 2012. Leuk Res. 2014 Mar; 38(3):299-303. Epub 2013 Sep 6
    View PubMed
  14. Baig NA, Taylor RP, Lindorfer MA, Church AK, LaPlant BR, Pettinger AM, Shanafelt TD, Nowakowski GS, Zent CS. Induced resistance to ofatumumab-mediated cell clearance mechanisms, including complement-dependent cytotoxicity, in chronic lymphocytic leukemia. J Immunol. 2014 Feb 15; 192(4):1620-9. Epub 2014 Jan 15.
    View PubMed
  15. Mansfield AS, Rabe KG, Slager SL, Schwager SM, Call TG, Brewer JD, Shanafelt TD. Skin cancer surveillance and malignancies of the skin in a community-dwelling cohort of patients with newly diagnosed chronic lymphocytic leukemia. J Oncol Pract. 2014 Jan 1; 10(1):e1-4. Epub 2013 Aug 27.
    View PubMed
  16. Shanafelt TD, Kaups KL, Nelson H, Satele DV, Sloan JA, Oreskovich MR, Dyrbye LN. An interactive individualized intervention to promote behavioral change to increase personal well-being in US surgeons. Ann Surg. 2014 Jan; 259(1):82-8.
    View PubMed
  17. Dyrbye LN, Sotile W, Boone S, West CP, Tan L, Satele D, Sloan J, Oreskovich M, Shanafelt T. A survey of U.S. physicians and their partners regarding the impact of work-home conflict. J Gen Intern Med. 2014 Jan; 29(1):155-61. Epub 2013 Sep 17.
    View PubMed
  18. Laurie CC, Laurie CA, Smoley SA, Carlson EE, Flinn I, Fridley BL, Greisman HA, Gribben JG, Jelinek DF, Nelson SC, Paietta E, Schaid D, Sun Z, Tallman MS, Weinshilboum R, Kay NE, Shanafelt TD. Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants. Cancer Genet. 2014 Jan-Feb; 207(1-2):19-30. Epub 2014 Jan 17.
    View PubMed
  19. Dyrbye LN, Sotile W, Boone S, West CP, Tan L, Satele D, Sloan J, Oreskovich M, Shanafelt T. A survey of us physicians and their partners regarding the impact of work-home conflict. J Gen Intern Med. 2014 Jan; 29(1):155-61.
  20. Parikh SA, Rabe KG, Kay NE, Call TG, Ding W, Schwager SM, Bowen DA, Conte M, Jelinek DF, Slager SL, Shanafelt TD. Chronic lymphocytic leukemia in young (</= 55 years) patients: a comprehensive analysis of prognostic factors and outcomes. Haematologica. 2014 Jan; 99(1):140-7. Epub 2013 Aug 2
    View PubMed
  21. Brewer JD, Habermann TM, Shanafelt TD. Lymphoma-associated skin cancer: Incidence, natural history, and clinical management. Int J Dermatol. 2014; 53(3):267-74.
  22. West CP, Dyrbye LN, Rabatin JT, Call TG, Davidson JH, Multari A, Romanski SA, Henriksen Hellyer JM, Sloan JA, Shanafelt TD. Intervention to promote physicianwell-being, job satisfaction, and professionalism a randomized clinical trial. JAMA Internal Medicine. 2014; 174(4):527-33.
  23. Shanafelt T. Treatment of older patients with chronic lymphocytic leukemia: key questions and current answers. Hematology-american Society Of Hematology Education Program. 2013 Dec; 158-67.
  24. Dyrbye LN, Varkey P, Boone SL, Satele DV, Sloan JA, Shanafelt TD. Physician satisfaction and burnout at different career stages. Mayo Clin Proc. 2013 Dec; 88(12):1358-67.
    View PubMed
  25. Weight CJ, Sellon JL, Lessard-Anderson CR, Shanafelt TD, Olsen KD, Laskowski ER. Physical activity, quality of life, and burnout among physician trainees: the effect of a team-based, incentivized exercise program. Mayo Clin Proc. 2013 Dec; 88(12):1435-42.
    View PubMed
  26. Shanafelt T, Lanasa MC, Call TG, Beaven AW, Leis JF, LaPlant B, Bowen D, Conte M, Jelinek DF, Hanson CA, Kay NE, Zent CS. Ofatumumab-based chemoimmunotherapy is effective and well tolerated in patients with previously untreated chronic lymphocytic leukemia (CLL). Cancer. 2013 Nov 1; 119(21):3788-96. Epub 2013 Aug 06.
    View PubMed
  27. Greipp PT, Smoley SA, Viswanatha DS, Frederick LS, Rabe KG, Sharma RG, Slager SL, Van Dyke DL, Shanafelt TD, Tschumper RC, Zent CS. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis. Br J Haematol. 2013 Nov; 163(3):326-33. Epub 2013 Aug 27.
    View PubMed
  28. Parikh SA, Kay NE, Shanafelt TD. Monoclonal B-cell lymphocytosis: update on diagnosis, clinical outcome, and counseling. Clin Adv Hematol Oncol. 2013 Nov; 11(11):720-9.
    View PubMed
  29. Ferrajoli A, Shanafelt TD, Ivan C, Shimizu M, Rabe KG, Nouraee N, Ikuo M, Ghosh AK, Lerner S, Rassenti LZ, Xiao L, Hu J, Reuben JM, Calin S, You MJ, Manning JT, Wierda WG, Estrov Z, O'Brien S, Kipps TJ, Keating MJ, Kay NE, Calin GA. Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia. Blood. 2013 Sep 12; 122(11):1891-9. Epub 2013 Jul 02.
    View PubMed
  30. Parikh SA, Rabe KG, Call TG, Zent CS, Habermann TM, Ding W, Leis JF, Schwager SM, Hanson CA, Macon WR, Kay NE, Slager SL, Shanafelt TD. Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients. Br J Haematol. 2013 Sep; 162(6):774-82. Epub 2013 Jul 11.
    View PubMed
  31. Lanasa MC, Kater AP, Shanafelt T, Fischer K. Highlights of the 7th young investigators' meeting on chronic lymphocytic leukemia. Leuk Lymphoma. 2013 Aug; 54(8):1815-6. Epub 2013 May 29.
    View PubMed
  32. Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Armstrong BK, Cocco P, Zhang Y, Severi G, Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet. 2013 Aug; 45(8):868-76. Epub 2013 Jun 16.
    View PubMed
  33. Witzig TE, Wiseman GA, Maurer MJ, Habermann TM, Micallef IN, Nowakowski GS, Ansell SM, Colgan JP, Inwards DJ, Porrata LF, Link BK, Zent CS, Johnston PB, Shanafelt TD, Allmer C, Asmann YW, Gupta M, Ballas ZK, Smith BJ, Weiner GJ. A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and 90 yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma. Am J Hematol. 2013 Jul; 88(7):589-93. Epub 2013 Jun 12.
    View PubMed
  34. Thompson CA, Hugo SE, Swetz KM, Novotny PJ, Sloan JA, Loprinzi CL, Moynihan TJ, Shanafelt TD. End-of-life care in a population-based cohort of cancer patients: clinical trial participation versus standard of care. BMJ Support Palliat Care. 2013 Jun; 3(2):181-7. Epub 2013 Mar 09.
    View PubMed
  35. Vardi A, Dagklis A, Scarfo L, Jelinek D, Newton D, Bennett F, Almeida J, Rodriguez-Caballero A, Allgood S, Lanasa M, Cortelezzi A, Orlandi E, Veronese S, Montillo M, Rawstron A, Shanafelt T, Orfao A, Stamatopoulos K, Ghia P. Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL. Blood. 2013 May 30; 121(22):4521-8. Epub 2013 Apr 17.
    View PubMed
  36. Shanafelt TD, Ramsay AG, Zent CS, Leis JF, Tun HW, Call TG, LaPlant B, Bowen D, Pettinger A, Jelinek DF, Hanson CA, Kay NE. Long-term repair of T-cell synapse activity in a phase II trial of chemoimmunotherapy followed by lenalidomide consolidation in previously untreated chronic lymphocytic leukemia (CLL). Blood. 2013 May 16; 121(20):4137-41. Epub 2013 Mar 14.
    View PubMed
  37. Solomon BM, Rabe KG, Slager SL, Brewer JD, Cerhan JR, Shanafelt TD. Overall and cancer-specific survival of patients with breast, colon, kidney, and lung cancers with and without chronic lymphocytic leukemia: a SEER population-based study. J Clin Oncol. 2013 Mar 1; 31(7):930-7. Epub 2013 Jan 22.
    View PubMed
  38. Dyrbye LN, Satele D, Sloan J, Shanafelt TD. Utility of a brief screening tool to identify physicians in distress. J Gen Intern Med. 2013 Mar; 28(3):421-7. Epub 2012 Nov 06.
    View PubMed
  39. Slager SL, Achenbach SJ, Asmann YW, Camp NJ, Rabe KG, Goldin LR, Call TG, Shanafelt TD, Kay NE, Cunningham JM, Wang AH, Weinberg JB, Norman AD, Link BK, Leis JF, Vachon CM, Lanasa MC, Caporaso NE, Novak AJ, Cerhan JR. Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes. Cancer Epidemiol Biomarkers Prev. 2013 Mar; 22(3):461-6. Epub 2013 Jan 10.
    View PubMed
  40. Shanafelt TD, Boone SL, Dyrbye LN, Oreskovich MR, Tan L, West CP, Satele DV, Sloan JA, Sotile WM. The medical marriage: a national survey of the spouses/partners of US physicians. Mayo Clin Proc. 2013 Mar; 88(3):216-25. Epub 2013 Feb 27.
    View PubMed
  41. Zent CS, Wu W, Bowen DA, Hanson CA, Pettinger AM, Shanafelt TD, Kay NE, Leis JF, Call TG. Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab. Leuk Lymphoma. 2013 Mar; 54(3):476-82. Epub 2012 Aug 22.
    View PubMed
  42. Yost KJ, Thompson CA, Eton DT, Allmer C, Ehlers SL, Habermann TM, Shanafelt TD, Maurer MJ, Slager SL, Link BK, Cerhan JR. The Functional Assessment of Cancer Therapy - General (FACT-G) is valid for monitoring quality of life in patients with non-Hodgkin lymphoma. Leuk Lymphoma. 2013 Feb; 54(2):290-7. Epub 2012 Sep 06.
    View PubMed
  43. Shanafelt TD, Call TG, Zent CS, Leis JF, LaPlant B, Bowen DA, Roos M, Laumann K, Ghosh AK, Lesnick C, Lee MJ, Yang CS, Jelinek DF, Erlichman C, Kay NE. Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer. 2013 Jan 15; 119(2):363-70. Epub 2012 Jul 03.
    View PubMed
  44. Moreira J, Rabe KG, Cerhan JR, Kay NE, Wilson JW, Call TG, Leis JF, Jelinek DF, Schwager SM, Bowen DA, Hanson CA, Slager SL, Shanafelt TD. Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls. Leukemia. 2013 Jan; 27(1):136-41. Epub 2012 Jul 11.
    View PubMed
  45. Kelly JL, Fredericksen ZS, Liebow M, Shanafelt TD, Thompson CA, Call TG, Habermann TM, Macon WR, Wang AH, Slager SL, Cerhan JR. The association between early life and adult body mass index and physical activity with risk of non-Hodgkin lymphoma: impact of gender. Ann Epidemiol. 2012 Dec; 22(12):855-62. Epub 2012 Nov 10.
    View PubMed
  46. West CP, Tan AD, Shanafelt TD. Association of resident fatigue and distress with occupational blood and body fluid exposures and motor vehicle incidents. Mayo Clin Proc. 2012 Dec; 87(12):1138-44.
    View PubMed
  47. Slager SL, Camp NJ, Conde L, Shanafelt TD, Achenbach SJ, Rabe KG, Kay NE, Novak AJ, Call TG, Bracci PM, Sille FM, Sanchez S, Akers NK, Cunningham JM, Serie DJ, McDonnell SK, Leis JF, Wang AH, Weinberg JB, Glenn M, Link B, Vachon CM, Lanasa MC, Skibola Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes. Br J Haematol. 2012 Dec; 159(5):572-6. Epub 2012 Oct 01.
    View PubMed
  48. Nieters A, Conde L, Slager SL, Brooks-Wilson A, Morton L, Skibola DR, Novak AJ, Riby J, Ansell SM, Halperin E, Shanafelt TD, Agana L, Wang AH, De Roos AJ, Severson RK, Cozen W, Spinelli J, Butterbach K, Becker N, de Sanjose S, Benavente Y, Cocco P, PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium. Blood. 2012 Nov 29; 120(23):4645-8. Epub 2012 Oct 09.
    View PubMed
  49. West CP, Dyrbye LN, Satele DV, Sloan JA, Shanafelt TD. Concurrent validity of single-item measures of emotional exhaustion and depersonalization in burnout assessment. J Gen Intern Med. 2012 Nov; 27(11):1445-52. Epub 2012 Feb 24.
    View PubMed
  50. Kater AP, Shanafelt T, Fischer K, Wierda W. Highlights of the 6th Young Investigators' Meeting on chronic lymphocytic leukemia. Leuk Lymphoma. 2012 Nov; 53(11):2312-3. Epub 2012 Aug 28.
    View PubMed
  51. Shanafelt TD, Boone S, Tan L, Dyrbye LN, Sotile W, Satele D, West CP, Sloan J, Oreskovich MR. Burnout and satisfaction with work-life balance among US physicians relative to the general US population. Arch Intern Med. 2012 Oct 8; 172(18):1377-85.
    View PubMed
  52. Dyrbye LN, West CP, Burriss TC, Shanafelt TD. Providing primary care in the United States: the work no one sees. Arch Intern Med. 2012 Oct 8; 172(18):1420-1.
    View PubMed
  53. Dyrbye LN, Freischlag J, Kaups KL, Oreskovich MR, Satele DV, Hanks JB, Sloan JA, Balch CM, Shanafelt TD. Work-home conflicts have a substantial impact on career decisions that affect the adequacy of the surgical workforce. Arch Surg. 2012 Oct; 147(10):933-9.
    View PubMed
  54. Swetz KM, Shanafelt TD, Drozdowicz LB, Sloan JA, Novotny PJ, Durst LA, Frantz RP, McGoon MD. Symptom burden, quality of life, and attitudes toward palliative care in patients with pulmonary arterial hypertension: results from a cross-sectional patient survey. J Heart Lung Transplant. 2012 Oct; 31(10):1102-8.
    View PubMed
  55. Dyrbye LN, Harper W, Moutier C, Durning SJ, Power DV, Massie FS, Eacker A, Thomas MR, Satele D, Sloan JA, Shanafelt TD. A multi-institutional study exploring the impact of positive mental health on medical students' professionalism in an era of high burnout. Acad Med. 2012 Aug; 87(8):1024-31.
    View PubMed
  56. Slager SL, Skibola CF, Di Bernardo MC, Conde L, Broderick P, McDonnell SK, Goldin LR, Croft N, Holroyd A, Harris S, Riby J, Serie DJ, Kay NE, Call TG, Bracci PM, Halperin E, Lanasa MC, Cunningham JM, Leis JF, Morrison VA, Spector LG, Vachon CM, Shanafelt Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood. 2012 Jul 26; 120(4):843-6. Epub 2012 Jun 13
    View PubMed
  57. Kelly JL, Drake MT, Fredericksen ZS, Asmann YW, Liebow M, Shanafelt TD, Feldman AL, Ansell SM, Macon WR, Herr MM, Wang AH, Nowakowski GS, Call TG, Habermann TM, Slager SL, Witzig TE, Cerhan JR. Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer Causes Control. 2012 Jul; 23(7):1017-29. Epub 2012 Apr 28.
    View PubMed
  58. Shanafelt T, Dyrbye L. Oncologist burnout: causes, consequences, and responses. J Clin Oncol. 2012 Apr 10; 30(11):1235-41. Epub 2012 Mar 12.
    View PubMed
  59. Shanafelt TD, Kay NE, Rabe KG, Inwards DJ, Zent CS, Leis JF, Schwager SM, Thompson CA, Bowen DA, Witzig TE, Slager SL, Call TG. Hematologist/oncologist disease-specific expertise and survival: lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Cancer. 2012 Apr 1; 118(7):1827-37. Epub 2011 Aug 26.
    View PubMed
  60. Shanafelt TD. Improving treatment for patients with chronic lymphocytic leukemia. Hematology. 2012 Apr; 17 Suppl 1:S133-6.
    View PubMed
  61. Shanafelt TD, Oreskovich MR, Dyrbye LN, Satele DV, Hanks JB, Sloan JA, Balch CM. Avoiding burnout: the personal health habits and wellness practices of US surgeons. Ann Surg. 2012 Apr; 255(4):625-33.
    View PubMed
  62. Brewer JD, Shanafelt TD, Otley CC, Roenigk RK, Cerhan JR, Kay NE, Weaver AL, Call TG. Chronic lymphocytic leukemia is associated with decreased survival of patients with malignant melanoma and Merkel cell carcinoma in a SEER population-based study. J Clin Oncol. 2012 Mar 10; 30(8):843-9. Epub 2012 Feb 13.
    View PubMed
  63. Beckman TJ, Reed DA, Shanafelt TD, West CP. Resident physician well-being and assessments of their knowledge and clinical performance. J Gen Intern Med. 2012 Mar; 27(3):325-30. Epub 2011 Sep 24.
    View PubMed
  64. Oreskovich MR, Kaups KL, Balch CM, Hanks JB, Satele D, Sloan J, Meredith C, Buhl A, Dyrbye LN, Shanafelt TD. Prevalence of alcohol use disorders among American surgeons. Arch Surg. 2012 Feb; 147(2):168-74.
    View PubMed
  65. Zent CS, Smith BJ, Ballas ZK, Wooldridge JE, Link BK, Call TG, Shanafelt TD, Bowen DA, Kay NE, Witzig TE, Weiner GJ. Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia. Leuk Lymphoma. 2012 Feb; 53(2):211-7. Epub 2011 Sep 19.
    View PubMed
  66. Dyrbye LN, Eacker AM, Harper W, Power DV, Massie FS Jr, Satele D, Thomas MR, Sloan JA, Shanafelt TD. Distress and empathy do not drive changes in specialty preference among US medical students. Med Teach. 2012; 34(2):e116-22.
    View PubMed
  67. Balch CM, Oreskovich MR, Dyrbye LN, Colaiano JM, Satele DV, Sloan JA, Shanafelt TD. Personal consequences of malpractice lawsuits on American surgeons. J Am Coll Surg. 2011 Nov; 213(5):657-67. Epub 2011 Sep 03.
    View PubMed
  68. Reed DA, Shanafelt TD, Satele DW, Power DV, Eacker A, Harper W, Moutier C, Durning S, Massie FS Jr, Thomas MR, Sloan JA, Dyrbye LN. Relationship of pass/fail grading and curriculum structure with well-being among preclinical medical students: a multi-institutional study. Acad Med. 2011 Nov; 86(11):1367-73.
    View PubMed
  69. Balch CM, Shanafelt TD, Sloan JA, Satele DV, Freischlag JA. Distress and career satisfaction among 14 surgical specialties, comparing academic and private practice settings. Ann Surg. 2011 Oct; 254(4):558-68.
    View PubMed
  70. Maurer MJ, Cerhan JR, Katzmann JA, Link BK, Allmer C, Zent CS, Call TG, Rabe KG, Hanson CA, Kay NE, Slager SL, Witzig TE, Shanafelt TD. Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia. Blood. 2011 Sep 8; 118(10):2821-6. Epub 2011 Jul 15.
    View PubMed
  71. West CP, Shanafelt TD, Kolars JC. Quality of life, burnout, educational debt, and medical knowledge among internal medicine residents. JAMA. 2011 Sep 7; 306(9):952-60.
    View PubMed
  72. Balch CM, Shanafelt T. Combating stress and burnout in surgical practice: a review. Thorac Surg Clin. 2011 Aug; 21(3):417-30.
    View PubMed
  73. Dyrbye LN, West CP, Satele D, Sloan JA, Shanafelt TD. Work/Home conflict and burnout among academic internal medicine physicians. Arch Intern Med. 2011 Jul 11; 171(13):1207-9.
    View PubMed
  74. Dyrbye LN, Schwartz A, Downing SM, Szydlo DW, Sloan JA, Shanafelt TD. Efficacy of a brief screening tool to identify medical students in distress. Acad Med. 2011 Jul; 86(7):907-14.
    View PubMed
  75. Fischer K, Shanafelt T, Kater AP. Highlights of the 5th Young Investigators' Meeting on chronic lymphocytic leukemia. Leuk Lymphoma. 2011 Jul; 52(7):1391-3.
    View PubMed
  76. Dyrbye LN, Shanafelt TD. Physician burnout: a potential threat to successful health care reform. JAMA. 2011 May 18; 305(19):2009-10.
    View PubMed
  77. Ghosh AK, Secreto C, Boysen J, Sassoon T, Shanafelt TD, Mukhopadhyay D, Kay NE. The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy. Blood. 2011 Feb 10; 117(6):1928-37. Epub 2010 Dec 6
    View PubMed
  78. Shanafelt TD, Drake MT, Maurer MJ, Allmer C, Rabe KG, Slager SL, Weiner GJ, Call TG, Link BK, Zent CS, Kay NE, Hanson CA, Witzig TE, Cerhan JR. Vitamin D insufficiency and prognosis in chronic lymphocytic leukemia. Blood. 2011 Feb 3; 117(5):1492-8. Epub 2010 Nov 03.
    View PubMed
  79. Dyrbye LN, Shanafelt TD, Balch CM, Satele D, Sloan J, Freischlag J. Relationship between work-home conflicts and burnout among American surgeons: a comparison by sex. Arch Surg. 2011 Feb; 146(2):211-7.
    View PubMed
  80. Shanafelt TD, Balch CM, Dyrbye L, Bechamps G, Russell T, Satele D, Rummans T, Swartz K, Novotny PJ, Sloan J, Oreskovich MR. Special report: suicidal ideation among American surgeons. Arch Surg. 2011 Jan; 146(1):54-62.
    View PubMed
  81. Balch CM, Shanafelt TD, Sloan J, Satele DV, Kuerer HM. Burnout and career satisfaction among surgical oncologists compared with other surgical specialties. Ann Surg Oncol. 2011 Jan; 18(1):16-25. Epub 2010 Oct 15.
    View PubMed
  82. Cerhan JR, Fredericksen ZS, Wang AH, Habermann TM, Kay NE, Macon WR, Cunningham JM, Shanafelt TD, Ansell SM, Call TG, Witzig TE, Slager SL, Liebow M. Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. Int J Mol Epidemiol Genet. 2011; 2(2):95-113. Epub 2011 Apr 05.
    View PubMed
  83. Dyrbye LN, Harper W, Durning SJ, Moutier C, Thomas MR, Massie FS Jr, Eacker A, Power DV, Szydlo DW, Sloan JA, Shanafelt TD. Patterns of distress in US medical students. Med Teach. 2011; 33(10):834-9.
    View PubMed
  84. Dyrbye LN, Moutier C, Durning SJ, Massie FS Jr, Power DV, Eacker A, Harper W, Thomas MR, Satele D, Sloan JA, Shanafelt TD. The problems program directors inherit: medical student distress at the time of graduation. Med Teach. 2011; 33(9):756-8.
    View PubMed
  85. Shanafelt T, Zent C, Byrd J, Erlichman C, Laplant B, Ghosh A, Call T, Villalona-Calero M, Jelinek D, Bowen D, Laumann K, Wu W, Hanson C, Kay N. Phase II trials of single-agent anti-VEGF therapy for patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2010 Dec; 51(12):2222-9. Epub 2010 Nov 05.
    View PubMed
  86. West CP, Shanafelt TD, Cook DA. Lack of association between resident doctors' well-being and medical knowledge. Med Educ. 2010 Dec; 44(12):1224-31.
    View PubMed
  87. Kay NE, Eckel-Passow JE, Braggio E, Vanwier S, Shanafelt TD, Van Dyke DL, Jelinek DF, Tschumper RC, Kipps T, Byrd JC, Fonseca R. Progressive but previously untreated CLL patients with greater array CGH complexity exhibit a less durable response to chemoimmunotherapy. Cancer Genet Cytogenet. 2010 Dec; 203(2):161-8.
    View PubMed
  88. Dyrbye LN, Shanafelt TD, Balch CM, Satele D, Freischlag J. Physicians married or partnered to physicians: a comparative study in the American College of Surgeons. J Am Coll Surg. 2010 Nov; 211(5):663-71.
    View PubMed
  89. Piderman KM, Marek DV, Jenkins SM, Johnson ME, Buryska JF, Shanafelt TD, O'Bryan FG, Hansen PD, Howick PH, Durland HL, Lackore KA, Lovejoy LA, Mueller PS. Predicting patients' expectations of hospital chaplains: a multisite survey. Mayo Clin Proc. 2010 Nov; 85(11):1002-10.
    View PubMed
  90. Balch CM, Shanafelt TD, Dyrbye L, Sloan JA, Russell TR, Bechamps GJ, Freischlag JA. Surgeon distress as calibrated by hours worked and nights on call. J Am Coll Surg. 2010 Nov; 211(5):609-19. Epub 2010 Sep 20.
    View PubMed
  91. Gutierrez A Jr, Tschumper RC, Wu X, Shanafelt TD, Eckel-Passow J, Huddleston PM 3rd, Slager SL, Kay NE, Jelinek DF. LEF-1 is a prosurvival factor in chronic lymphocytic leukemia and is expressed in the preleukemic state of monoclonal B-cell lymphocytosis. Blood. 2010 Oct 21; 116(16):2975-83. Epub 2010 Jul 01.
    View PubMed
  92. Shanafelt TD, Rabe KG, Kay NE, Zent CS, Jelinek DF, Reinalda MS, Schwager SM, Bowen DA, Slager SL, Hanson CA, Call TG. Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia. Cancer. 2010 Oct 15; 116(20):4777-87.
    View PubMed
  93. Dyrbye LN, Power DV, Massie FS, Eacker A, Harper W, Thomas MR, Szydlo DW, Sloan JA, Shanafelt TD. Factors associated with resilience to and recovery from burnout: a prospective, multi-institutional study of US medical students. Med Educ. 2010 Oct; 44(10):1016-26.
    View PubMed
  94. Dyrbye LN, Massie FS Jr, Eacker A, Harper W, Power D, Durning SJ, Thomas MR, Moutier C, Satele D, Sloan J, Shanafelt TD. Relationship between burnout and professional conduct and attitudes among US medical students. JAMA. 2010 Sep 15; 304(11):1173-80.
    View PubMed
  95. Shanafelt T, Bosch F. The IV International Chronic Lymphocytic Leukemia Young Investigators' Meeting. Leuk Lymphoma. 2010 Aug; 51(8):1369-70.
    View PubMed
  96. Shanafelt TD, Rabe KG, Kay NE, Zent CS, Call TG, Slager SL, Bowen DA, Schwager SM, Nowakowski GS. Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia. Leuk Lymphoma. 2010 Jul; 51(7):1233-40.
    View PubMed
  97. Shanafelt TD, Balch CM, Bechamps G, Russell T, Dyrbye L, Satele D, Collicott P, Novotny PJ, Sloan J, Freischlag J. Burnout and medical errors among American surgeons. Ann Surg. 2010 Jun; 251(6):995-1000.
    View PubMed
  98. Kay NE, Wu W, Kabat B, LaPlant B, Lin TS, Byrd JC, Jelinek DF, Grever MR, Zent CS, Call TG, Shanafelt TD. Pentostatin and rituximab therapy for previously untreated patients with B-cell chronic lymphocytic leukemia. Cancer. 2010 May 1; 116(9):2180-7.
    View PubMed
  99. Bowen DA, Call TG, Shanafelt TD, Kay NE, Schwager SM, Reinalda MS, Rabe KG, Slager SL, Zent CS. Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia/small lymphocytic lymphoma with rituximab, cyclophosphamide, vincristine, and prednisone. Leuk Lymphoma. 2010 Apr; 51(4):620-7.
    View PubMed
  100. Shanafelt TD, Ghia P, Lanasa MC, Landgren O, Rawstron AC. Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management. Leukemia. 2010 Mar; 24(3):512-20. Epub 2010 Jan 21.
    View PubMed
  101. Van Dyke DL, Shanafelt TD, Call TG, Zent CS, Smoley SA, Rabe KG, Schwager SM, Sonbert JC, Slager SL, Kay NE. A comprehensive evaluation of the prognostic significance of 13q deletions in patients with B-chronic lymphocytic leukaemia. Br J Haematol. 2010 Feb; 148(4):544-50. Epub 2009 Nov 06.
    View PubMed
  102. Beckman TJ, Reed DA, Shanafelt TD, West CP. Impact of resident well-being and empathy on assessments of faculty physicians. J Gen Intern Med. 2010 Jan; 25(1):52-6. Epub 2009 Oct 31.
    View PubMed
  103. Dyrbye LN, Thomas MR, Power DV, Durning S, Moutier C, Massie FS Jr, Harper W, Eacker A, Szydlo DW, Sloan JA, Shanafelt TD. Burnout and serious thoughts of dropping out of medical school: a multi-institutional study. Acad Med. 2010 Jan; 85(1):94-102.
    View PubMed
  104. Dyrbye LN, Szydlo DW, Downing SM, Sloan JA, Shanafelt TD. Development and preliminary psychometric properties of a well-being index for medical students. BMC Med Educ. 2010; 10:8. Epub 2010 Jan 27.
    View PubMed
  105. Balch CM, Shanafelt T. Combating stress and burnout in surgical practice: a review. Adv Surg. 2010; 44:29-47.
    View PubMed
  106. Rawstron AC, Shanafelt T, Lanasa MC, Landgren O, Hanson C, Orfao A, Hillmen P, Ghia P. Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL). Cytometry B Clin Cytom. 2010; 78B(Suppl 1):S19-23.
  107. Caporaso NE, Marti GE, Landgren O, Azzato E, Weinberg JB, Goldin L, Shanafelt T. Monoclonal B cell lymphocytosis: clinical and population perspectives. Cytometry B Clin Cytom. 2010; 78B(Suppl 1):S115-9.
  108. Shanafelt TD, Gunderson H, Call TG. Commentary: chronic lymphocytic leukemia--the price of progress. Oncologist. 2010; 15(6):601-2. Epub 2010 May 12
    View PubMed
  109. Dronca RS, Jevremovic D, Hanson CA, Rabe KG, Shanafelt TD, Morice WG, Call TG, Kay NE, Collins CS, Schwager SM, Slager SL, Zent CS. CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity. Cytometry B Clin Cytom. 2010; 78 Suppl 1:S35-41.
    View PubMed
  110. West CP, Dyrbye LN, Sloan JA, Shanafelt TD. Single item measures of emotional exhaustion and depersonalization are useful for assessing burnout in medical professionals. J Gen Intern Med. 2009 Dec; 24(12):1318-21. Epub 2009 Oct 03.
    View PubMed
  111. Ding W, Nowakowski GS, Knox TR, Boysen JC, Maas ML, Schwager SM, Wu W, Wellik LE, Dietz AB, Ghosh AK, Secreto CR, Medina KL, Shanafelt TD, Zent CS, Call TG, Kay NE. Bi-directional activation between mesenchymal stem cells and CLL B-cells: implication for CLL disease progression. Br J Haematol. 2009 Nov; 147(4):471-83. Epub 2009 Sep 08.
    View PubMed
  112. Rahmatpanah FB, Carstens S, Hooshmand SI, Welsh EC, Sjahputera O, Taylor KH, Bennett LB, Shi H, Davis JW, Arthur GL, Shanafelt TD, Kay NE, Wooldridge JE, Caldwell CW. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia. Epigenomics. 2009 Oct; 1(1):39-61.
    View PubMed
  113. West CP, Tan AD, Habermann TM, Sloan JA, Shanafelt TD. Association of resident fatigue and distress with perceived medical errors. JAMA. 2009 Sep 23; 302(12):1294-300.
    View PubMed
  114. Shanafelt TD, Balch CM, Bechamps GJ, Russell T, Dyrbye L, Satele D, Collicott P, Novotny PJ, Sloan J, Freischlag JA. Burnout and career satisfaction among American surgeons. Ann Surg. 2009 Sep; 250(3):463-71.
    View PubMed
  115. Swetz KM, Harrington SE, Matsuyama RK, Shanafelt TD, Lyckholm LJ. Strategies for avoiding burnout in hospice and palliative medicine: peer advice for physicians on achieving longevity and fulfillment. J Palliat Med. 2009 Sep; 12(9):773-7.
    View PubMed
  116. Shanafelt TD, Byrd JC, LaPLant B, Zent CS, Call T, Secreto C, Grever MR, Lin TS, Kay NE. Pretreatment angiogenic cytokines predict response to chemoimmunotherapy in patients with chronic lymphocytic leukaemia. Br J Haematol. 2009 Sep; 146(6):660-4. Epub 2009 Jul 10.
    View PubMed
  117. Shanafelt TD, Kay NE, Rabe KG, Call TG, Zent CS, Maddocks K, Jenkins G, Jelinek DF, Morice WG, Boysen J, Schwager S, Bowen D, Slager SL, Hanson CA. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia. J Clin Oncol. 2009 Aug 20; 27(24):3959-63. Epub 2009 Jul 20.
    View PubMed
  118. Shanafelt TD, Call TG, Zent CS, LaPlant B, Bowen DA, Roos M, Secreto CR, Ghosh AK, Kabat BF, Lee MJ, Yang CS, Jelinek DF, Erlichman C, Kay NE. Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia. J Clin Oncol. 2009 Aug 10; 27(23):3808-14. Epub 2009 May 26.
    View PubMed
  119. Zent CS, Ding W, Reinalda MS, Schwager SM, Hoyer JD, Bowen DA, Jelinek DF, Tschumper RC, Call TG, Shanafelt TD, Kay NE, Slager SL. Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis. Leuk Lymphoma. 2009 Aug; 50(8):1261-8.
    View PubMed
  120. Tam CS, Shanafelt TD, Wierda WG, Abruzzo LV, Van Dyke DL, O'Brien S, Ferrajoli A, Lerner SA, Lynn A, Kay NE, Keating MJ. De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience. Blood. 2009 Jul 30; 114(5):957-64. Epub 2009 May 4
    View PubMed
  121. Nowakowski GS, Shanafelt TD, Schwager S, Kay NE. Reply to R.S. Go. J Clin Oncol. 2009 Jul 06. [Epub ahead of print]
    View PubMed
  122. Ghosh AK, Shanafelt TD, Cimmino A, Taccioli C, Volinia S, Liu CG, Calin GA, Croce CM, Chan DA, Giaccia AJ, Secreto C, Wellik LE, Lee YK, Mukhopadhyay D, Kay NE. Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood. 2009 May 28; 113(22):5568-74. Epub 2009 Mar 31.
    View PubMed
  123. Shanafelt TD, West CP, Sloan JA, Novotny PJ, Poland GA, Menaker R, Rummans TA, Dyrbye LN. Career fit and burnout among academic faculty. Arch Intern Med. 2009 May 25; 169(10):990-5.
    View PubMed
  124. Shanafelt TD, Kay NE, Jenkins G, Call TG, Zent CS, Jelinek DF, Morice WG, Boysen J, Zakko L, Schwager S, Slager SL, Hanson CA. B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood. 2009 Apr 30; 113(18):4188-96. Epub 2008 Nov 17
    View PubMed
  125. Nowakowski GS, Hoyer JD, Shanafelt TD, Zent CS, Call TG, Bone ND, Laplant B, Dewald GW, Tschumper RC, Jelinek DF, Witzig TE, Kay NE. Percentage of smudge cells on routine blood smear predicts survival in chronic lymphocytic leukemia. J Clin Oncol. 2009 Apr 10; 27(11):1844-9. Epub 2009 Mar 02.
    View PubMed
  126. Kay NE, Shanafelt TD, Call TG, Wu W, Laplant BR. N9986: a phase II trial of thalidomide in patients with relapsed chronic lymphocytic leukemia. Leuk Lymphoma. 2009 Apr; 50(4):588-92.
    View PubMed
  127. Balch CM, Freischlag JA, Shanafelt TD. Stress and burnout among surgeons: understanding and managing the syndrome and avoiding the adverse consequences. Arch Surg. 2009 Apr; 144(4):371-6.
    View PubMed
  128. Shanafelt T, Hanson CA. Monoclonal B-cell lymphocytosis: definitions and natural history. Leuk Lymphoma. 2009 Mar; 50(3):493-7.
    View PubMed
  129. Dyrbye LN, Shanafelt TD, Thomas MR, Durning SJ. Brief observation: a national study of burnout among internal medicine clerkship directors. Am J Med. 2009 Mar; 122(3):310-2.
    View PubMed
  130. Dyrbye LN, Thomas MR, Harper W, Massie FS Jr, Power DV, Eacker A, Szydlo DW, Novotny PJ, Sloan JA, Shanafelt TD. The learning environment and medical student burnout: a multicentre study. Med Educ. 2009 Mar; 43(3):274-82.
    View PubMed
  131. Ghosh AK, Kay NE, Secreto CR, Shanafelt TD. Curcumin inhibits prosurvival pathways in chronic lymphocytic leukemia B cells and may overcome their stromal protection in combination with EGCG. Clin Cancer Res. 2009 Feb 15; 15(4):1250-8.
    View PubMed
  132. Shanafelt TD, Bowen DA, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Tun H, Sloan JA, Call TG. The physician-patient relationship and quality of life: lessons from chronic lymphocytic leukemia. Leuk Res. 2009 Feb; 33(2):263-70. Epub 2008 Jul 25.
    View PubMed
  133. Shanafelt TD, Jenkins G, Call TG, Zent CS, Slager S, Bowen DA, Schwager S, Hanson CA, Jelinek DF, Kay NE. Validation of a new prognostic index for patients with chronic lymphocytic leukemia. Cancer. 2009 Jan 15; 115(2):363-72.
    View PubMed
  134. Awan FT, Kay NE, Davis ME, Wu W, Geyer SM, Leung N, Jelinek DF, Tschumper RC, Secreto CR, Lin TS, Grever MR, Shanafelt TD, Zent CS, Call TG, Heerema NA, Lozanski G, Byrd JC, Lucas DM. Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximab. Blood. 2009 Jan 15; 113(3):535-7. Epub 2008 Nov 13.
    View PubMed
  135. Shanafelt TD. Predicting clinical outcome in CLL: how and why. Hematology Am Soc Hematol Educ Program. 2009; 421-9.
    View PubMed
  136. Zent CS, Secreto CR, LaPlant BR, Bone ND, Call TG, Shanafelt TD, Jelinek DF, Tschumper RC, Kay NE. Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab. Leuk Res. 2008 Dec; 32(12):1849-56. Epub 2008 Jun 27.
    View PubMed
  137. Shanafelt TD, West CP, Poland GA, LaRusso NF, Menaker R, Bahn RS. Principles to promote physician satisfaction and work-life balance. Minn Med. 2008 Dec; 91(12):41-3.
    View PubMed
  138. Shanafelt T. In Reply: More on Burnout and Surgical Oncology. Ann Surg Oncol. 2008 Nov 13. [Epub ahead of print]
    View PubMed
  139. Zent CS, Call TG, Shanafelt TD, Tschumper RC, Jelinek DF, Bowen DA, Secreto CR, Laplant BR, Kabat BF, Kay NE. Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab. Cancer. 2008 Oct 15; 113(8):2110-8.
    View PubMed
  140. Dyrbye LN, Thomas MR, Massie FS, Power DV, Eacker A, Harper W, Durning S, Moutier C, Szydlo DW, Novotny PJ, Sloan JA, Shanafelt TD. Burnout and suicidal ideation among U.S. medical students. Ann Intern Med. 2008 Sep 2; 149(5):334-41.
    View PubMed
  141. Shanafelt TD, Kay NE, Call TG, Zent CS, Jelinek DF, LaPlant B, Morice WG, Hanson CA. MBL or CLL: which classification best categorizes the clinical course of patients with an absolute lymphocyte count >or= 5 x 10(9) L(-1) but a B-cell lymphocyte count <5 x 10(9) L(-1)? Leuk Res. 2008 Sep; 32(9):1458-61. Epub 2008 Jan 07.
    View PubMed
  142. Kuerer HM, Breslin T, Shanafelt TD, Baile WF, Crawford W, Balch CM. Road map for maintaining career satisfaction and balance in surgical oncology. J Am Coll Surg. 2008 Sep; 207(3):435-42. Epub 2008 May 19.
    View PubMed
  143. Morice WG, Kurtin PJ, Hodnefield JM, Shanafelt TD, Hoyer JD, Remstein ED, Hanson CA. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. Mayo Clin Proc. 2008 Jul; 83(7):776-85.
    View PubMed
  144. Goitein L, Shanafelt TD, Nathens AB, Curtis JR. Effects of resident work hour limitations on faculty professional lives. J Gen Intern Med. 2008 Jul; 23(7):1077-83.
    View PubMed
  145. Nabhan C, Shanafelt TD, Kay NE. Controversies in the front-line management of chronic lymphocytic leukemia. Leuk Res. 2008 May; 32(5):679-88. Epub 2008 Jan 11.
    View PubMed
  146. Palmer S, Hanson CA, Zent CS, Porrata LF, Laplant B, Geyer SM, Markovic SN, Call TG, Bowen DA, Jelinek DF, Kay NE, Shanafelt TD. Prognostic importance of T and NK-cells in a consecutive series of newly diagnosed patients with chronic lymphocytic leukaemia. Br J Haematol. 2008 May; 141(5):607-14. Epub 2008 Apr 01.
    View PubMed
  147. Zent CS, Ding W, Schwager SM, Reinalda MS, Hoyer JD, Jelinek DF, Tschumper RC, Bowen DA, Call TG, Shanafelt TD, Kay NE, Slager SL. The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma. Br J Haematol. 2008 May; 141(5):615-21. Epub 2008 Mar 27.
    View PubMed
  148. Shanafelt TD, Geyer SM, Bone ND, Tschumper RC, Witzig TE, Nowakowski GS, Zent CS, Call TG, Laplant B, Dewald GW, Jelinek DF, Kay NE. CD49d expression is an independent predictor of overall survival in patients with chronic lymphocytic leukaemia: a prognostic parameter with therapeutic potential. Br J Haematol. 2008 Mar; 140(5):537-46.
    View PubMed
  149. Shanafelt T. A career in surgical oncology: finding meaning, balance, and personal satisfaction. Ann Surg Oncol. 2008 Feb; 15(2):400-6. Epub 2007 Dec 12.
    View PubMed
  150. Thurmes P, Call T, Slager S, Zent C, Jenkins G, Schwager S, Bowen D, Kay N, Shanafelt T. Comorbid conditions and survival in unselected, newly diagnosed patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2008 Jan; 49(1):49-56.
    View PubMed
  151. Tschumper RC, Geyer SM, Campbell ME, Kay NE, Shanafelt TD, Zent CS, Nowakowski GS, Call TG, Dewald GW, Jelinek DF. Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients. J Clin Invest. 2008 Jan; 118(1):306-15.
    View PubMed
  152. Bowen DA, Call TG, Jenkins GD, Zent CS, Schwager SM, Van Dyke DL, Jelinek DF, Kay NE, Shanafelt TD. Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features. Leuk Lymphoma. 2007 Dec; 48(12):2412-7.
    View PubMed
  153. Browning RL, Geyer SM, Johnson AJ, Jelinek DF, Tschumper RC, Call TG, Shanafelt TD, Zent CS, Bone ND, Dewald GW, Lin TS, Heerema NA, Grever MR, Kay NE, Byrd JC, Lucas DM. Expression of TCL-1 as a potential prognostic factor for treatment outcome in B-cell chronic lymphocytic leukemia. Leuk Res. 2007 Dec; 31(12):1737-40. Epub 2007 Jul 19.
    View PubMed
  154. Maddocks-Christianson K, Slager SL, Zent CS, Reinalda M, Call TG, Habermann TM, Bowen DA, Hoyer JD, Schwager S, Jelinek DF, Kay NE, Shanafelt TD. Risk factors for development of a second lymphoid malignancy in patients with chronic lymphocytic leukaemia. Br J Haematol. 2007 Nov; 139(3):398-404.
    View PubMed
  155. Kuerer HM, Eberlein TJ, Pollock RE, Huschka M, Baile WF, Morrow M, Michelassi F, Singletary SE, Novotny P, Sloan J, Shanafelt TD. Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology. Ann Surg Oncol. 2007 Nov; 14(11):3043-53. Epub 2007 Sep 09.
    View PubMed
  156. Dyrbye LN, Thomas MR, Eacker A, Harper W, Massie FS Jr, Power DV, Huschka M, Novotny PJ, Sloan JA, Shanafelt TD. Race, ethnicity, and medical student well-being in the United States. Arch Intern Med. 2007 Oct 22; 167(19):2103-9.
    View PubMed
  157. Shanafelt TD, Bowen D, Venkat C, Slager SL, Zent CS, Kay NE, Reinalda M, Sloan JA, Call TG. Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients. Br J Haematol. 2007 Oct; 139(2):255-64.
    View PubMed
  158. West CP, Shanafelt TD. Physician well-being and professionalism. Minn Med. 2007 Aug; 90(8):44-6.
    View PubMed
  159. Kay NE, Shanafelt TD, Strege AK, Lee YK, Bone ND, Raza A. Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an "angiogenic switch". Leuk Res. 2007 Jul; 31(7):899-906. Epub 2007 Jan 22.
    View PubMed
  160. Dyrbye LN, Thomas MR, Mechaber AJ, Eacker A, Harper W, Massie FS Jr, Power DV, Shanafelt TD. Medical education research and IRB review: an analysis and comparison of the IRB review process at six institutions. Acad Med. 2007 Jul; 82(7):654-60.
    View PubMed
  161. Shanafelt TD, Lin T, Geyer SM, Zent CS, Leung N, Kabat B, Bowen D, Grever MR, Byrd JC, Kay NE. Pentostatin, cyclophosphamide, and rituximab regimen in older patients with chronic lymphocytic leukemia. Cancer. 2007 Jun 1; 109(11):2291-8.
    View PubMed
  162. West CP, Huntington JL, Huschka MM, Novotny PJ, Sloan JA, Kolars JC, Habermann TM, Shanafelt TD. A prospective study of the relationship between medical knowledge and professionalism among internal medicine residents. Acad Med. 2007 Jun; 82(6):587-92.
    View PubMed
  163. Nowakowski GS, Hoyer JD, Shanafelt TD, Geyer SM, LaPlant BR, Call TG, Jelinek DF, Zent CS, Kay NE. Using smudge cells on routine blood smears to predict clinical outcome in chronic lymphocytic leukemia: a universally available prognostic test. Mayo Clin Proc. 2007 Apr; 82(4):449-53.
    View PubMed
  164. Martin W, Abraham R, Shanafelt T, Clark RJ, Bone N, Geyer SM, Katzmann JA, Bradwell A, Kay NE, Witzig TE. Serum-free light chain-a new biomarker for patients with B-cell non-Hodgkin lymphoma and chronic lymphocytic leukemia. Transl Res. 2007 Apr; 149(4):231-5.
    View PubMed
  165. Kay NE, Shanafelt TD. Prognostic factors in chronic lymphocytic leukemia. Curr Hematol Malig Rep. 2007 Feb; 2(1):49-55.
    View PubMed
  166. Thomas MR, Dyrbye LN, Huntington JL, Lawson KL, Novotny PJ, Sloan JA, Shanafelt TD. How do distress and well-being relate to medical student empathy? A multicenter study. J Gen Intern Med. 2007 Feb; 22(2):177-83.
    View PubMed
  167. Kay NE, Geyer SM, Call TG, Shanafelt TD, Zent CS, Jelinek DF, Tschumper R, Bone ND, Dewald GW, Lin TS, Heerema NA, Smith L, Grever MR, Byrd JC. Combination chemoimmunotherapy with pentostatin, cyclophosphamide, and rituximab shows significant clinical activity with low accompanying toxicity in previously untreated B chronic lymphocytic leukemia. Blood. 2007 Jan 15; 109(2):405-11. Epub 2006 Sep 28.
    View PubMed
  168. West CP, Shanafelt TD. The influence of personal and environmental factors on professionalism in medical education. BMC Med Educ. 2007; 7:29. Epub 2007 Aug 30.
    View PubMed
  169. Shanafelt TD, Kay NE. Comprehensive management of the CLL patient: a holistic approach. Hematology Am Soc Hematol Educ Program. 2007; 324-31.
    View PubMed
  170. Dyrbye LN, Thomas MR, Huschka MM, Lawson KL, Novotny PJ, Sloan JA, Shanafelt TD. A multicenter study of burnout, depression, and quality of life in minority and nonminority US medical students. Mayo Clin Proc. 2006 Nov; 81(11):1435-42.
    View PubMed
  171. Shanafelt TD, Witzig TE, Fink SR, Jenkins RB, Paternoster SF, Smoley SA, Stockero KJ, Nast DM, Flynn HC, Tschumper RC, Geyer S, Zent CS, Call TG, Jelinek DF, Kay NE, Dewald GW. Prospective evaluation of clonal evolution during long-term follow-up of patients with untreated early-stage chronic lymphocytic leukemia. J Clin Oncol. 2006 Oct 1; 24(28):4634-41.
    View PubMed
  172. Shanafelt TD, Byrd JC, Call TG, Zent CS, Kay NE. Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia. Ann Intern Med. 2006 Sep 19; 145(6):435-47.
    View PubMed
  173. West CP, Huschka MM, Novotny PJ, Sloan JA, Kolars JC, Habermann TM, Shanafelt TD. Association of perceived medical errors with resident distress and empathy: a prospective longitudinal study. JAMA. 2006 Sep 6; 296(9):1071-8.
    View PubMed
  174. Zent CS, Call TG, Hogan WJ, Shanafelt TD, Kay NE. Update on risk-stratified management for chronic lymphocytic leukemia. Leuk Lymphoma. 2006 Sep; 47(9):1738-46.
    View PubMed
  175. Shanafelt T, Chung H, White H, Lyckholm LJ. Shaping your career to maximize personal satisfaction in the practice of oncology. J Clin Oncol. 2006 Aug 20; 24(24):4020-6.
    View PubMed
  176. Shanafelt T, Kay N. T-cell abnormalities in patients with chronic lymphocytic leukemia. Leuk Lymphoma. 2006 Jul; 47(7):1197-8.
    View PubMed
  177. Shanafelt TD, Lee YK, Call TG, Nowakowski GS, Dingli D, Zent CS, Kay NE. Clinical effects of oral green tea extracts in four patients with low grade B-cell malignancies. Leuk Res. 2006 Jun; 30(6):707-12. Epub 2005 Dec 01.
    View PubMed
  178. Fink SR, Smoley SA, Stockero KJ, Paternoster SF, Thorland EC, Van Dyke DL, Shanafelt TD, Zent CS, Call TG, Kay NE, Dewald GW. Loss of TP53 is due to rearrangements involving chromosome region 17p10 approximately p12 in chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2006 Jun; 167(2):177-81.
    View PubMed
  179. Stockero KJ, Fink SR, Smoley SA, Paternoster SF, Shanafelt TD, Call TG, Zent CS, Van Dyke DL, Kay NE, Dewald GW. Metaphase cells with normal G-bands have cryptic interstitial deletions in 13q14 detectable by fluorescence in situ hybridization in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet. 2006 Apr 15; 166(2):152-6.
    View PubMed
  180. Dyrbye LN, Thomas MR, Shanafelt TD. Systematic review of depression, anxiety, and other indicators of psychological distress among U.S. and Canadian medical students. Acad Med. 2006 Apr; 81(4):354-73.
    View PubMed
  181. Dyrbye LN, Thomas MR, Huntington JL, Lawson KL, Novotny PJ, Sloan JA, Shanafelt TD. Personal life events and medical student burnout: a multicenter study. Acad Med. 2006 Apr; 81(4):374-84.
    View PubMed
  182. Shanafelt TD, Kay NE. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia. Semin Oncol. 2006 Apr; 33(2):174-85.
    View PubMed
  183. Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, Slager S, Witzig TE, Shanafelt T, Call TG, Kay NE, Jelinek DF, Cerhan JR, Gross JA, Harder B, Dillon SR, Ansell SM. Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders. J Clin Oncol. 2006 Feb 20; 24(6):983-7. Epub 2006 Jan 23.
    View PubMed
  184. Barton DL, Loprinzi C, Atherton PJ, Kottschade L, Collins M, Carpenter P, Adjei A, Rummans TA, Shanafelt T, Christensen B, Sloan J. Dehydroepiandrosterone for the treatment of hot flashes: a pilot study. Support Cancer Ther. 2006 Jan 1; 3(2):91-7.
    View PubMed
  185. Goitein L, Shanafelt TD, Wipf JE, Slatore CG, Back AL. The effects of work-hour limitations on resident well-being, patient care, and education in an internal medicine residency program. Arch Intern Med. 2005 Dec 12; 165(22):2601-6.
    View PubMed
  186. Pittner BT, Shanafelt TD, Kay NE, Jelinek DF. CD38 expression levels in chronic lymphocytic leukemia B cells are associated with activation marker expression and differential responses to interferon stimulation. Leukemia. 2005 Dec; 19(12):2264-72.
    View PubMed
  187. Dyrbye LN, Thomas MR, Shanafelt TD. Medical student distress: causes, consequences, and proposed solutions. Mayo Clin Proc. 2005 Dec; 80(12):1613-22.
    View PubMed
  188. Loprinzi CL, Flynn PJ, Carpenter LA, Atherton P, Barton DL, Shanafelt TD, Rummans TA, Sloan JA, Adjei AA, Mincey BA, Fitch TR, Collins M. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. J Palliat Med. 2005 Oct; 8(5):924-30.
    View PubMed
  189. Nowakowski GS, Dewald GW, Hoyer JD, Paternoster SF, Stockero KJ, Fink SR, Smoley SA, Remstein ED, Phyliky RL, Call TG, Shanafelt TD, Kay NE, Zent CS. Interphase fluorescence in situ hybridization with an IGH probe is important in the evaluation of patients with a clinical diagnosis of chronic lymphocytic leukaemia. Br J Haematol. 2005 Jul; 130(1):36-42.
    View PubMed
  190. Shanafelt TD, West C, Zhao X, Novotny P, Kolars J, Habermann T, Sloan J. Relationship between increased personal well-being and enhanced empathy among internal medicine residents. J Gen Intern Med. 2005 Jul; 20(7):559-64.
    View PubMed
  191. Lee YK, Shanafelt TD, Bone ND, Strege AK, Jelinek DF, Kay NE. VEGF receptors on chronic lymphocytic leukemia (CLL) B cells interact with STAT 1 and 3: implication for apoptosis resistance. Leukemia. 2005 Apr; 19(4):513-23.
    View PubMed
  192. Shanafelt TD, Lee YK, Bone ND, Strege AK, Narayanan VL, Sausville EA, Geyer SM, Kaufmann SH, Kay NE. Adaphostin-induced apoptosis in CLL B cells is associated with induction of oxidative stress and exhibits synergy with fludarabine. Blood. 2005 Mar 1; 105(5):2099-106. Epub 2004 Sep 23.
    View PubMed
  193. Fink SR, Paternoster SF, Smoley SA, Flynn HC, Geyer SM, Shanafelt TD, Lee YK, Jelinek DF, Kay NE, Dewald GW. Fluorescent-labeled DNA probes applied to novel biological aspects of B-cell chronic lymphocytic leukemia. Leuk Res. 2005 Mar; 29(3):253-62.
    View PubMed
  194. Shanafelt TD. Finding meaning, balance, and personal satisfaction in the practice of oncology. J Support Oncol. 2005 Mar-Apr; 3(2):157-62, 164.
    View PubMed
  195. Shanafelt TD, Novotny P, Johnson ME, Zhao X, Steensma DP, Lacy MQ, Rubin J, Sloan J. The well-being and personal wellness promotion strategies of medical oncologists in the North Central Cancer Treatment Group. Oncology. 2005; 68(1):23-32. Epub 2005 Mar 16.
    View PubMed
  196. Dyrbye LN, Thomas MR, Lawson K, Novotny PJ, Huntington JL, Sloan JA, Shanafelt TD. A multicenter study of depression, alcohol usage, and burnout in American medical students. J Gen Intern Med. 2005; 20(Suppl 1):145.
  197. Lee YK, Bone ND, Strege AK, Shanafelt TD, Jelinek DF, Kay NE. VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia. Blood. 2004 Aug 1; 104(3):788-94. Epub 2004 Mar 02.
    View PubMed
  198. Shanafelt TD, Loprinzi C, Marks R, Novotny P, Sloan J. Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer? J Clin Oncol. 2004 May 15; 22(10):1966-74.
    View PubMed
  199. Shanafelt TD, Call TG. Current approach to diagnosis and management of chronic lymphocytic leukemia. Mayo Clin Proc. 2004 Mar; 79(3):388-98.
    View PubMed
  200. Shanafelt TD, Geyer SM, Kay NE. Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL. Blood. 2004 Feb 15; 103(4):1202-10. Epub 2003 Oct 23.
    View PubMed
  201. Shanafelt TD, Madueme HL, Wolf RC, Tefferi A. Rituximab for immune cytopenia in adults: idiopathic thrombocytopenic purpura, autoimmune hemolytic anemia, and Evans syndrome. Mayo Clin Proc. 2003 Nov; 78(11):1340-6.
    View PubMed
  202. Shanafelt T, Adjei A, Meyskens FL. When your favorite patient relapses: Physician grief and well-being in the practice of oncology. J Clin Oncol. 2003 Jul 1; 21(13):2616-9.
    View PubMed
  203. Barton DL, Loprinzi CL, Novotny P, Shanafelt T, Sloan J, Wahner-Roedler D, Rummans TA, Christensen B, Dakhill SR, Martin LS. Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol. 2003 May-Jun; 1(1):47-51.
    View PubMed
  204. Shanafelt TD, Sloan JA, Habermann TM. The well-being of physicians. Am J Med. 2003 Apr 15; 114(6):513-9.
    View PubMed
  205. Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist. 2003; 8(5):474-87.
    View PubMed
  206. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and treatment of hot flashes. Mayo Clin Proc. 2002 Nov; 77(11):1207-18.
    View PubMed
  207. Shanafelt TD, Bradley KA, Wipf JE, Back AL. Burnout and self-reported patient care in an internal medicine residency program. Ann Intern Med. 2002 Mar 5; 136(5):358-67.
    View PubMed
  208. Suh CI, Shanafelt T, May DJ, Shroyer KR, Bobak JB, Crawford ED, Miller GJ, Markham N, Glode LM. Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer. Mol Cell Probes. 2000 Aug; 14(4):211-7.
    View PubMed